Comparison between Empyrean Cashews IPO and Evoq Remedies IPO.
Empyrean Cashews IPO is a SME Fixed Price IPO proposed to list at NSE SME while Evoq Remedies IPO is a SME Fixed Price proposed to list at BSE SME.
| Empyrean Cashews IPO | Evoq Remedies IPO | |
|---|---|---|
| Logo |  |  |
| Issue Category | SME | SME |
| Issue Type | IPO | IPO |
| Process Type | Fixed Price | Fixed Price |
| Listing At | NSE SME | BSE SME |
| Lead Managers | Systematix Corporate Services Ltd. | Swastika Investmart Ltd. |
| Registrar | Purva Sharegistry (India) Pvt.Ltd. | Bigshare Services Pvt.Ltd. |
| Market Maker | Systematix Shares & Stocks (India) Ltd. | Sunflower Broking Pvt.Ltd. |
| DRHP | DRHP  | DRHP |
| RHP | RHP | RHP |
| Final Prospectus | Final Prospectus | Final Prospectus |
| Anchor Investor | ||
| IPO Allotment URL | IPO Allotment URL | IPO Allotment URL |
The total issue size of Empyrean Cashews IPO is up to ₹18.44 Cr whereas the issue size of the Evoq Remedies IPO is up to ₹9.23 Cr. The final issue price of Empyrean Cashews IPO is ₹37.00 per share and of Evoq Remedies IPO is ₹27.00 per share.
| Empyrean Cashews IPO | Evoq Remedies IPO | |
|---|---|---|
| Face Value | ₹10 per share | ₹10 per share |
| Issue Price (Lower) | ||
| Issue Price (Upper) | ||
| Issue Price (Final) | ₹37.00 per share | ₹27.00 per share |
| Discount (Retail) | ₹0.00 per share | ₹0.00 per share |
| Discount (Employee) | ||
| Market Lot Size | 3000 shares | 4000 shares |
| Fresh Issue Size | 49,83,000 shares | 34,20,000 shares |
| Fresh Issue Size (Amount) | up to ₹18.44 Cr | up to ₹9.23 Cr |
| OFS Issue Size | 0 shares | 0 shares |
| OFS Issue Size (Amount) | up to ₹0.00 Cr | up to ₹0.00 Cr |
| Issue Size Total | 49,83,000 shares | 34,20,000 shares |
| Issue Size Total (Amount) | up to ₹18.44 Cr | up to ₹9.23 Cr |
Empyrean Cashews IPO opens on Mar 21, 2022, while Evoq Remedies IPO opens on Mar 17, 2022. The closing date of Empyrean Cashews IPO and Evoq Remedies IPO is Mar 23, 2022, and Mar 22, 2022, respectively.
| Empyrean Cashews IPO | Evoq Remedies IPO | |
|---|---|---|
| Anchor Bid Date | ||
| Issue Open | Mar 21, 2022 | Mar 17, 2022 |
| Issue Close | Mar 23, 2022 | Mar 22, 2022 |
| Basis Of Allotment (Tentative) | Mar 28, 2022 | Mar 25, 2022 |
| Initiation of Refunds (Tentative) | Mar 30, 2022 | Mar 28, 2022 |
| Credit of Share (Tentative) | Mar 30, 2022 | Mar 29, 2022 |
| Listing date (Tentative) | Mar 31, 2022 | Mar 30, 2022 |
| Anchor Lockin End date 1 | ||
| Anchor Lockin End date 2 |
Empyrean Cashews IPO P/E ratio is 25.69, as compared to Evoq Remedies IPO P/E ratio of 33.75.
| Empyrean Cashews IPO | Evoq Remedies IPO | |||||
|---|---|---|---|---|---|---|
| Financials | Company Financials ()
| Company Financials ()
| ||||
| Promoter Shareholding (Pre-Issue) | 56.99 | 99.99 | ||||
| Promoter Shareholding (Post-Issue) | 41.88 | 73.53 | ||||
| P/E Ratio | 25.69 | 33.75 | ||||
| Market Cap | ₹73.24 Cr. | ₹36.72 Cr. | ||||
| ROE | ||||||
| ROCE | ||||||
| Debt/Equity | ||||||
| EPS | ₹0.46 | ₹10.05 | ||||
| RoNW | 3.44 | 96.94 |
In the Empyrean Cashews IPO Retail Individual Investors (RII) are offered 24,91,500 shares while in Evoq Remedies IPO retail investors are offered 24,91,500 shares. Qualified Institutional Buyers (QIB) are offered in Empyrean Cashews IPO and in Evoq Remedies IPO.
| Empyrean Cashews IPO | Evoq Remedies IPO | |
|---|---|---|
| Anchor Investor Reservation | ||
| Market Maker Reservation | 2,64,000 shares | 1,80,000 shares |
| QIB | ||
| NII | 24,91,500 shares | 17,10,000 shares |
| RII | 24,91,500 shares | 17,10,000 shares |
| Employee | ||
| Others | ||
| Total | 49,83,000 shares | 34,20,000 shares |
Empyrean Cashews IPO subscribed 2.28x in total, whereas Evoq Remedies IPO subscribed 1.67x.
| Empyrean Cashews IPO | Evoq Remedies IPO | |
|---|---|---|
| QIB (times) | ||
| NII (times) | 2.92x | 0.30x |
| Big NII (times) | ||
| Small NII (times) | ||
| RII (times) | 1.63x | 3.03x |
| Employee (times) | ||
| Other (times) | ||
| Total (times) | 2.28x | 1.67x |
